VC-backed Neuraptive appoints Radie as CEO

Neuraptive Therapeutics Inc, a developer of new treatments for peripheral nerve injuries, has named Robert S. Radie as CEO.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this